Stockholder alert: robbins llp informs investors of the ess pharma inc. class action

San diego , jan. 27, 2025 /prnewswire/ -- robbins llp informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired essa pharma inc. (nasdaq: epix) securities between december 12, 2023 and october 31, 2024. essa is a clinical stage pharmaceutical company that focuses on the development of small molecule drugs for the treatment of prostate cancer.
ESS Ratings Summary
ESS Quant Ranking